Correlation Between Inovio Pharmaceuticals and Cardiff Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inovio Pharmaceuticals and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inovio Pharmaceuticals and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inovio Pharmaceuticals and Cardiff Oncology, you can compare the effects of market volatilities on Inovio Pharmaceuticals and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inovio Pharmaceuticals with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inovio Pharmaceuticals and Cardiff Oncology.

Diversification Opportunities for Inovio Pharmaceuticals and Cardiff Oncology

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Inovio and Cardiff is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Inovio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inovio Pharmaceuticals are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Inovio Pharmaceuticals i.e., Inovio Pharmaceuticals and Cardiff Oncology go up and down completely randomly.

Pair Corralation between Inovio Pharmaceuticals and Cardiff Oncology

Considering the 90-day investment horizon Inovio Pharmaceuticals is expected to generate 0.45 times more return on investment than Cardiff Oncology. However, Inovio Pharmaceuticals is 2.22 times less risky than Cardiff Oncology. It trades about -0.41 of its potential returns per unit of risk. Cardiff Oncology is currently generating about -0.23 per unit of risk. If you would invest  562.00  in Inovio Pharmaceuticals on September 6, 2024 and sell it today you would lose (149.00) from holding Inovio Pharmaceuticals or give up 26.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Inovio Pharmaceuticals  vs.  Cardiff Oncology

 Performance 
       Timeline  
Inovio Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inovio Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Cardiff Oncology 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cardiff Oncology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental indicators, Cardiff Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Inovio Pharmaceuticals and Cardiff Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inovio Pharmaceuticals and Cardiff Oncology

The main advantage of trading using opposite Inovio Pharmaceuticals and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inovio Pharmaceuticals position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.
The idea behind Inovio Pharmaceuticals and Cardiff Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments